The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predicting positive bone marrow biopsies (BMBs) in patients (PTS) with advanced prostate cancer (APC).
David Lorente
No relevant relationships to disclose
Aurelius Gabriel Omlin
No relevant relationships to disclose
Carmel Jo Pezaro
No relevant relationships to disclose
Nina Tunariu
No relevant relationships to disclose
Roberta Ferraldeschi
No relevant relationships to disclose
Ruth Riisnaes
No relevant relationships to disclose
Joaquin Mateo
No relevant relationships to disclose
Elizabeth Sheridan
No relevant relationships to disclose
Raquel Perez Lopez
No relevant relationships to disclose
Daniel Nava Rodrigues
No relevant relationships to disclose
Mateus Crespo
No relevant relationships to disclose
Ines Figueiredo
No relevant relationships to disclose
Zafeiris Zafeirou
No relevant relationships to disclose
Amelia Altavilla
No relevant relationships to disclose
Gerhardt Attard
No relevant relationships to disclose
Johann Sebastian De Bono
No relevant relationships to disclose